By Jaya Ramachandran
GENEVA (IDN) — In the first-ever “analysis of bacterial vaccines in preclinical and clinical development: 2021”, the World Health Organization (WHO) has called for “equitable and global access to the vaccines that already exist, especially among populations that need them most” because of limited resources at their disposal.
This report is part of the WHO efforts to inform sustainable investment in research and development of new medicines, diagnostic tools, and other interventions to control AMR (antimicrobial resistance).
- Kalinga Seneviratne
- Goal 3